Frankfurt - Delayed Quote • EUR
Chemed Corporation (CXM.F)
At close: April 26 at 8:01 AM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 4.52 | 4.88 | 17.94 | 19.3 |
| Low Estimate | 4.5 | 4.84 | 16.43 | 18.22 |
| High Estimate | 4.56 | 4.91 | 18.48 | 20.33 |
| Year Ago EPS | 4.86 | 5.13 | 18.08 | 17.94 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 531.87M | 543.42M | 2.14B | 2.23B |
| Low Estimate | 530.72M | 541.98M | 2.13B | 2.21B |
| High Estimate | 532.7M | 544.92M | 2.14B | 2.24B |
| Year Ago Sales | -- | 533.29M | 2.08B | 2.14B |
| Sales Growth (year/est) | -- | 1.90% | 2.70% | 4.30% |
Earnings History
| CURRENCY IN USD | 9/30/2020 | 12/31/2020 | 3/31/2021 | 6/30/2021 |
|---|---|---|---|---|
| EPS Est. | 3.97 | 5.13 | 4.02 | 4.29 |
| EPS Actual | 4.86 | 5.13 | 4.44 | 4.6 |
| Difference | 0.89 | 0 | 0.42 | 0.31 |
| Surprise % | 22.40% | 0.00% | 10.40% | 7.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | 4.52 | 4.88 | 17.94 | 19.3 |
| 7 Days Ago | 4.52 | 4.88 | 17.94 | 19.3 |
| 30 Days Ago | 4.52 | 4.88 | 17.94 | 19.3 |
| 60 Days Ago | 4.41 | 4.79 | 17.54 | 18.46 |
| 90 Days Ago | 4.38 | 4.66 | 17.77 | 19.01 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CXM.F | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -7.00% | -- | -- | 6.50% |
| Next Qtr. | -4.90% | -- | -- | 12.00% |
| Current Year | -0.80% | -- | -- | 5.30% |
| Next Year | 7.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 7.55% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 18.23% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | RBC Capital: Outperform to Outperform | 3/4/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 2/29/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 1/17/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 10/30/2023 |
| Maintains | RBC Capital: Outperform to Outperform | 7/31/2023 |
| Maintains | Oppenheimer: Outperform to Outperform | 7/27/2023 |
Related Tickers
PRF.SG ModivCare Inc
118.00
0.00%
XXY.F Cross Country Healthcare, Inc.
15.90
-1.24%
ZCY.F Cryo-Cell International, Inc.
7.00
+5.26%
PDC.F Pediatrix Medical Group, Inc.
8.15
-4.12%
PRF0.F ModivCare Inc.
22.00
-3.51%
BICX BioCorRx Inc.
0.7500
-8.54%
CCEL Cryo-Cell International, Inc.
8.45
+8.33%
NHC National HealthCare Corporation
91.28
+0.56%
ACHC Acadia Healthcare Company, Inc.
73.59
+0.29%
CLARI.PA Clariane SE
1.8800
+18.69%